Jump to: Reports and Analyses | Podcast | Videos | Infographics | Blog
Reports and Analyses
Featured
Jump to: Reports and Analyses | Podcast | Videos | Infographics | Blog
Reports and Analyses
Podcast
Certain patients with chronic diseases such as diabetes who have high deductible health plans may see some out-of-pocket relief soon. In this episode, John Anderson, MD, talks about the patient experience now and potential implications of a new policy.
When it comes to rising insulin prices, pharmacy benefit managers are “driving the bus” explains George Huntley. In this episode, George describes the dynamics that continue to push insulin out of patients’ reach.
Frank Lavernia, MD, explains how insulin pricing has evolved, why it’s becoming unaffordable and what that means for diabetes patients. He also describes a new trend in pharmacies’ distribution of insulin pens.
Videos
Blog
“A few of my patients are kids. Others are over age 90. But nearly all are overweight or obese.
As a clinical lipidologist – a cholesterol expert – practicing in preventive cardiology, I’ve learned to expect this connection between lipids like cholesterol and triglycerides, pre- and outright diabetes and body weight.”
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
It can take 17 years for medical breakthroughs to move from the lab to the clinic, where patients can finally benefit. Why the lag?
Heart disease and Type 2 diabetes aren’t just common. They commonly occur together. So why does the health care system force patients with both conditions to treat one disease at a time?
The pandemic has forced many Americans to re-examine their approach to life’s challenges and identify ways to be more efficient in changing times. The same should apply to treating people who live with diabetes.
ABC News chief medical correspondent Dr. Jennifer Ashton talks about the importance of being your own advocate and asking your doctor about being screened for diabetes.